179 related articles for article (PubMed ID: 31594538)
21. GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH.
Yang R; Liu N; Chen L; Jiang Y; Shi Y; Mao C; Liu Y; Wang M; Lai W; Tang H; Gao M; Xiao D; Wang X; Zhou H; Tang CE; Liu W; Yu F; Cao Y; Yan Q; Liu S; Tao Y
Oncogene; 2019 Nov; 38(46):7133-7145. PubMed ID: 31417184
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability.
Wu H; Yang P; Hu W; Wang Y; Lu Y; Zhang L; Fan Y; Xiao H; Li Z
Oncotarget; 2016 Nov; 7(47):78069-78082. PubMed ID: 27801666
[TBL] [Abstract][Full Text] [Related]
23. Regulation of p53 and MDM2 activity by MTBP.
Brady M; Vlatkovic N; Boyd MT
Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
[TBL] [Abstract][Full Text] [Related]
24. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
Nardinocchi L; Puca R; Givol D; D'Orazi G
FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
[TBL] [Abstract][Full Text] [Related]
25. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
[TBL] [Abstract][Full Text] [Related]
26. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
27. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
Okamoto K; Taya Y; Nakagama H
FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
[TBL] [Abstract][Full Text] [Related]
28. USP11 regulates p53 stability by deubiquitinating p53.
Ke JY; Dai CJ; Wu WL; Gao JH; Xia AJ; Liu GP; Lv KS; Wu CL
J Zhejiang Univ Sci B; 2014 Dec; 15(12):1032-8. PubMed ID: 25471832
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop.
Yeom S; Kim SS; Jeong H; Jang KL
J Gen Virol; 2017 Jul; 98(7):1774-1784. PubMed ID: 28714848
[TBL] [Abstract][Full Text] [Related]
30. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
[TBL] [Abstract][Full Text] [Related]
31. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.
Klusmann I; Wohlberedt K; Magerhans A; Teloni F; Korbel JO; Altmeyer M; Dobbelstein M
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11311-E11320. PubMed ID: 30413623
[TBL] [Abstract][Full Text] [Related]
32. Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.
Wei J; Yang Y; Lu M; Xu L; Liu F; Yuan Z; Bao Q; Jiang Z; Xu X; Guo X; Zhang X; You Q; Sun H
Anticancer Agents Med Chem; 2015; 16(2):174-89. PubMed ID: 26343143
[TBL] [Abstract][Full Text] [Related]
33. Critical role for Daxx in regulating Mdm2.
Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
[TBL] [Abstract][Full Text] [Related]
34. LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer.
Yang R; Liu N; Chen L; Jiang Y; Shi Y; Mao C; Liu Y; Wang M; Lai W; Tang H; Gao M; Xiao D; Wang X; Yu F; Cao Y; Yan Q; Liu S; Tao Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):280. PubMed ID: 31253190
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma.
Ma J; Peng J; Mo R; Ma S; Wang J; Zang L; Li W; Fan J
Biochem Biophys Res Commun; 2015 Aug; 464(1):147-53. PubMed ID: 26102039
[TBL] [Abstract][Full Text] [Related]
36. p53 mediates the negative regulation of MDM2 by orphan receptor TR3.
Zhao BX; Chen HZ; Lei NZ; Li GD; Zhao WX; Zhan YY; Liu B; Lin SC; Wu Q
EMBO J; 2006 Dec; 25(24):5703-15. PubMed ID: 17139261
[TBL] [Abstract][Full Text] [Related]
37. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
38. Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.
Saleme B; Gurtu V; Zhang Y; Kinnaird A; Boukouris AE; Gopal K; Ussher JR; Sutendra G
Sci Transl Med; 2019 Feb; 11(478):. PubMed ID: 30728290
[TBL] [Abstract][Full Text] [Related]
39. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
40. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
